Abstract | BACKGROUND:
COVID-19 has spread worldwide and has caused significant morbidity and mortality. Myocardial injury and thrombo- embolism are known complications for those with severe forms of disease. The incidence and risk factors for these complications for those patients who are asymptomatic or with mild forms of COVID-19 is unknown. CASE SUMMARY: DISCUSSION: Recognition that mild COVID-19 can be complicated by subsequent cardiac injury and/or coagulopathy is important. As more people recover from this viral illness and return to normal activity levels, discussion among cardiac experts has begun regarding screening for occult myocardial injury in those who plan to resume competitive athletic activity. This case highlights the need for investigation regarding (i) the duration of thrombophilia after recovery from illness; (ii) the population that should receive thromboprophylaxis; and (iii) the duration of thromboprophylaxis therapy for COVID-19.
|
Authors | Lauren S Ranard, David J Engel, Ajay J Kirtane, Amirali Masoumi |
Journal | European heart journal. Case reports
(Eur Heart J Case Rep)
Vol. 4
Issue 5
Pg. 1-5
(Oct 2020)
ISSN: 2514-2119 [Electronic] England |
PMID | 33200109
(Publication Type: Case Reports)
|
Copyright | © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. |